Our subgroup analysis revealed that the positivity rate of the CellCollector assay in diagnosing IFCCs was higher than that of the real‐time PCR (CEA) method in CRC patients with T3 and T4 stages. The gene discussed is CEACAM5; the disease is colorectal carcinoma.